Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-06-27

FDA Approved: URSODIOL — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Ursodiol by Actavis Pharma, Inc., updating its labeling and indications. The action likely expands or refines ho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • URSODIOL (ursodiol)

Snippet

SUPPL AP for URSODIOL (URSODIOL)